The typhoid vaccine is a immunization used to prevent typhoid fever, primarily targeting infections caused by Salmonella typhi. The vaccine stimulates the human immune system to produce specific antibodies, thereby providing protection against typhoid fever.
Typhoid vaccines are generally categorized into two types: live attenuated vaccines and polysaccharide conjugate vaccines. Live attenuated vaccines work by weakening the virus or bacteria to stimulate an immune response, while polysaccharide conjugate vaccines link the pathogen's polysaccharide antigens to a carrier protein to enhance the immune response.
Live attenuated vaccines are administered orally and are commonly used in children and adults. They work by allowing the weakened bacteria or virus to cause a mild infection in the body, which stimulates the production of immunity against typhoid. When a true infection occurs, the body already has specific antibodies and immune cells to resist the infection.
Polysaccharide conjugate vaccines are given via injection, typically used for infants and immunocompromised individuals. The polysaccharide antigens in these vaccines provoke a stronger immune response, especially in infants, and are more effective. The advantage of conjugate vaccines is their ability to provide longer-lasting immunity.
The typhoid vaccine is mainly used to prevent typhoid fever, especially in endemic areas or high-risk populations. It is suitable for all age groups, including infants, children, and adults. For individuals with weakened immune systems or chronic illnesses (such as diabetes, heart disease, etc.), vaccination against typhoid is particularly important, as these groups are at higher risk of infection and may face more severe complications.
Live attenuated vaccines are usually administered orally, with a dose of 1 to 2 tablets. It is recommended to take the vaccine after drinking clean water and to avoid eating or drinking immediately afterward to ensure vaccine efficacy. The oral vaccine typically requires a single dose and does not need a booster.
Polysaccharide conjugate vaccines are administered via intramuscular or subcutaneous injection, usually a 0.5 mL dose. It is recommended to start vaccination at 6 months of age for infants, while adults only need a single dose for long-term protection. After vaccination, it is advised to observe the patient for about 30 minutes to monitor for any severe allergic reactions.
The main advantage of the typhoid vaccine is its effectiveness in preventing typhoid fever, thereby reducing hospitalization and mortality rates associated with the disease. Studies show that vaccination can reduce the incidence of typhoid by 80% to 90%. Additionally, the vaccine can decrease the infectiousness of carriers, thereby reducing disease transmission within communities.
Another significant benefit is the long-term protective effect. The protection duration of polysaccharide conjugate vaccines is usually 5 to 7 years, while live attenuated vaccines offer slightly shorter protection, approximately 3 to 5 years. This makes the vaccine particularly useful for high-risk populations, as it provides sustained protection and reduces the need for multiple doses.
After vaccination, some mild side effects may occur. Common side effects include pain, redness, and induration at the injection site. Oral vaccines may cause mild diarrhea or headache. These side effects are usually mild and resolve within a few days.
Although rare, severe allergic reactions can occur, including difficulty breathing, facial swelling, and throat closure. If these symptoms appear, immediate medical attention is necessary. Therefore, it is recommended to observe the patient in the hospital for some time after vaccination to promptly manage any allergic reactions.
The main contraindications for the typhoid vaccine include individuals allergic to vaccine components and those who have previously experienced severe allergic reactions to vaccination. Pregnant and breastfeeding women should consult their doctor before vaccination to assess potential risks and benefits.
Additionally, immunocompromised individuals, such as HIV-infected persons or those undergoing chemotherapy, should be vaccinated under medical supervision, as their immune response may be weaker. These individuals might require additional doses or alternative vaccination strategies to ensure effectiveness.
The interaction between typhoid vaccines and other medications or treatments is minimal but still requires attention. For example, patients on immunosuppressants, such as corticosteroids or chemotherapy drugs, may experience reduced vaccine efficacy because these medications suppress immune responses.
Furthermore, the use of antibiotics may affect the vaccine's effectiveness. Therefore, all medications being used should be disclosed to the doctor before vaccination so that potential interactions can be evaluated and treatment plans adjusted accordingly.
Extensive clinical trials have confirmed the efficacy of typhoid vaccines in preventing the disease. Studies show a significant reduction in typhoid incidence following vaccination, especially in high-endemic areas. For example, some studies report over 90% reduction in disease occurrence after polysaccharide conjugate vaccination.
Long-term protective effects of the vaccine have also been verified. Research indicates that immunity can last several years post-vaccination, providing long-term protection for recipients. This underscores the importance of vaccination in controlling disease spread from a public health perspective.
If the typhoid vaccine is unavailable or unsuitable, other preventive measures should be considered. These include improving sanitation, providing safe drinking water and food, and conducting health education to reduce infection risk. In some cases, doctors may recommend prophylactic antibiotics, but this is typically reserved for high-risk groups or specific situations.
Another alternative is vaccination with other types of vaccines, such as typhoid conjugate vaccines for typhoid, but these mainly target different diseases and have limited efficacy against typhoid itself. Therefore, the typhoid vaccine remains the best option for prevention.
Choosing the appropriate typhoid vaccine depends on your health status, travel plans, and the vaccine's duration of effectiveness. There are two main types: an oral live attenuated vaccine suitable for individuals over 6 years old, with a validity of 5 years; and an injectable vaccine suitable for those aged 2 and above, with a validity of 2 years. It is recommended to get vaccinated at least 2 weeks before travel to ensure sufficient antibody production.
What should I pay attention to after receiving the typhoid vaccine?After vaccination, mild side effects such as pain or redness at the injection site, or slight fever, may occur. These symptoms usually resolve within a few days. If you received the oral vaccine, avoid eating or drinking within 1 hour after vaccination, and avoid acidic foods within 2 hours to ensure vaccine efficacy.
Is it safe for pregnant and breastfeeding women to receive the typhoid vaccine?According to current medical guidelines, pregnant and breastfeeding women can receive the typhoid vaccine under certain circumstances, but it should be done under medical supervision. Pregnant women planning to travel to high-risk areas may be advised to receive the injectable vaccine, while oral vaccines are generally not recommended. Breastfeeding women can safely receive any type of typhoid vaccine without affecting the infant.
Does vaccination guarantee complete protection against typhoid?The typhoid vaccine significantly reduces the risk of infection but does not provide 100% protection. The efficacy typically ranges from 50% to 90%, depending on the vaccine type and individual health. Therefore, even after vaccination, preventive measures such as avoiding untreated water, undercooked food, and maintaining good personal hygiene are essential.
What is the best age for children to receive the typhoid vaccine?Children can start receiving the injectable typhoid vaccine from 2 years old, while the oral live attenuated vaccine is recommended from 6 years old. To ensure safety during travel, it is advised to complete vaccination at least 2 weeks before visiting high-risk areas. Parents should consult with a pediatrician in advance to ensure the vaccination aligns with the child's health condition.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
